Pay in 4 interest-free payments of $6.22 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
announced the decision to discontinue the development of danuglipron (PF-06882961), an oral glucagon-like peptide-1 (GLP-1) receptor agonist, which was being investigated for chronic weight management
Effects of meal ingestion on plasma amylin concentration in NIDDM and nondiabetic humans
Am J Physiol Regul Integr Comp
HbA1c reductions were approximately 2 percentage points at the higher doses, comparable to or larger than the figures published earlier for tirzepatide in the SURPASS programme
US$ 23.59
US$ 24.33
US$ 22.05
US$ 22.43
US$ 21.11
US$ 26.62
